Shi Chen

9PUBLICATIONS
36CO-AUTHORS
Molecular targetsPredictive and prognostic markersLiquid biopsiesCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jul 23, 2026
KRASG12D inhibition reprograms the tumor-induced immunosuppressive environment and enhances NK cell-mediated antitumor immunity.

|Mar 02, 2026
A predictive model for postoperative hemorrhage in patients with clinically relevant pancreatic fistula following minimally invasive pancreaticoduodenectomy.

Yuhong Pan, Dihang Wu, Jianlin Lai

|Nov 22, 2025
Targeting SERPINB3-MAPK axis-mediated cuproptosis resistance enhances the response to antitumor immunotherapy.

Xiao-Xiao Huang, Cheng-Ke Xie, Yi-Chao Mo

|Jul 21, 2025
SenExo-cCCT2 Reprograms Senescence Response and Anti-Tumor Immunity Following FOLFIRINOX Chemotherapy in Pancreatic Ductal Adenocarcinoma.

Shuncang Zhu, Yinhao Chen, Hongyi Lin

|Jun 30, 2025
TRAF3IP2-AS1 Deficiency Induces Necroptosis to Promote Pancreatic Cancer Liver Metastasis.

Yong-Ding Wu, Xiao-Xiao Huang, Hao-Xiang Zhang

|Mar 15, 2025
Laparoscopic versus open secondary hepatectomy treating postoperative regional recurrent hepatolithiasis: a multicenter real-world study.

Dihang Wu, Long Huang, Chengyu Liao

Pageof 2

Frequent Collaborators

5 joint publications

Zuwei Wang

3 joint publications

Cheng-Yu Liao

3 joint publications

Yi-Feng Tian

2 joint publications

Ge Li